3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1/2
1
Status
Recruiting
3
Sponsor Class
INDUSTRY
11
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Stomach Neoplasms
2
Gastric Cancer Adenocarcinoma Metastatic
1
Interventions
pembrolizumab
603
Cyclophosphamide
547
Magnetic Resonance Spectroscopy
527
Radiotherapy
511
Specimen Handling
505
Nivolumab
412
Cisplatin
380
Carboplatin
371
Blood Specimen Collection
304
Biopsy
304
Radiosurgery
287
Paclitaxel
285
Gemcitabine
272
Surveys and Questionnaires
270
Standard of Care
267
fludarabine
265
Dexamethasone
263
Drug Therapy
262
venetoclax
251
Bevacizumab
249
Oxaliplatin
210
Capecitabine
202
Rituximab
198
Radiation
191
Fluorouracil
191
Ipilimumab
189
durvalumab
185
Doxorubicin
179
Etoposide
177
atezolizumab
169
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
zolbetuximab
×
1 year
×
Clear all
NCT06468280
2026-01-21
ROSETTE
Shanghai Zhongshan Hospital
Phase 2
Recruiting
84 enrolled
NCT06962137
2025-12-22
RAINSPOT
Universitaire Ziekenhuizen KU Leuven
Phase 2
Recruiting
100 enrolled
NCT06732856
2025-07-28
NEO-CLAUD
Asan Medical Center
Phase 1/2
Recruiting
57 enrolled